Real World Evidence Solutions Market is expected to grow at a CAGR of 14 during the forecast period of (2019 – 2024)

Real World Evidence Solutions

(2019 – 2024) “Real World Evidence Solutions Market Report studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Real World Evidence Solutions Analysis. The Real World Evidence Solutions market is expected to register a CAGR of approximately 14% during the forecast period of (2019 – 2024).

Real World Evidence Solutions Market Report Covers Leading Manufacturers: Clinigen, Icon PLC, IBM, Iqvia, Oracle, Parexel, Perkinelmer, Pharmaceutical Product Development (PPD), SAS Institute, and Syneos Health among others.

Get Sample PDF of Report –

The Global Real World Evidence Solutions Market is expected to register a CAGR of nearly 14% during 2018-2023 (the forecast period). Real World Evidence Solutions Market refers to services that enable healthcare payers, providers and pharmaceutical companies to efficiently manage their operations, and pharma companies to fasten drug development and approval process.

Delays in Drug Development and the Subsequent Increase in Development Costs

For pharmaceutical companies to bring a new drug molecule to market, it takes several years with increasing drug development lifecycle. They invest billions of dollars in research and development with little probability of success. To shorten the drug development cycles pharma research centers need a clear insight into treatment options that work in a wide population compared to few patient pool in clinical trials. The use of Real-world evidence (RWE) insights is increasing because pharma and biotech companies believe that RWE can be important in drug development and life-cycle management and also increase efficiency in innovation and cost of clinical trials. Big pharmaceutical companies use a clinical-genomic database with tumor sequencing information for cancer discovery studies and targeted drug development. Companies are able to broaden their indication range and conduct a small number of clinical trials for rare biomarker-defined population, thus this is contributing for the growth of real world evidence solutions market. Other factors which are driving the Real World Evidence Solutions Market growth are the shift from volume to value-based care and increasing aging population and prevalence of chronic diseases.

Unwillingness to Rely On Real-World Studies

Not all people have uniform access to real-world databases for research. There are also data security concerns for allowing access to data. Though the insights from RWE is valuable, the lack of any standardization of the analytical methods used for RWE generation restricts many players to rely on real-world studies. There are concerns about data collection, analyzing techniques and the reported data as the RWE output depends on prospective and retrospective studies. More often data collected via different sources are biased and when integrated to perform a quality analysis robust techniques are to be used to minimize the error in outcomes. The ethical use of real-world data is a challenge and many countries like Denmark are developing a national database for disclosing information. While in the UK and US the major concern is about the data privacy and accountability for giving access to information. There is no defined standard on how much data disclosure is sufficient and for what purposes, is necessary to ensure confidence in RWE. Regulatory Policies for data collection of real-world data vary across different countries that impacts the quality of data collected, thus restraining the growth of real world evidence solutions market.

The US Lead the Market in North America Region

In the United States, the 21st Century Cures Act passed in 2016 that establishes public-private partnerships in data collection to gain insights on diseases that help in targeted drug development and clinical trials design. The act ensures trusted exchange of electronic health information securely that promotes patient safety and ensures data integrity. Regulators like FDA use Real World Evidence data for monitoring post-market safety and make decisions such as approving a new indication for a previously approved drug. The FDA also wants to evaluate real-time evidence from individual EHR of at least 10 million individuals across all healthcare setting. In the United States with decreasing revenue margins due to value-based payments hospitals with a wide scale of operations are depending on real time evidence based analysis. Most real world data bases are in United States and Europe. All the above factors may propel the growth of Real World Evidence Solutions market in United States over the forecasted period.

Order a Copy Of Real World Evidence Solutions Market Report

Reasons to Purchase Real World Evidence Solutions Market Report:

  • Identification of key factors instrumental in changing the market scenario, exploiting new opportunities, and gaining a competitive edge. 
  • Analysing various perspectives of the market with the help of Porter’s five forces analysis.
  • The authentication mode is likely to witness the highest adoption of these systems in the market.
  • The regions that are expected to witness the fastest growth during the forecast period.
  • The SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicators.
  • 3 months’ analyst support along with the Market Estimate sheet (in excel). 

Customization of the Report:

  • This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

About 360 Market Updates:

360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:

Name: Mr. Ajay More

Email: [email protected]

Phone: +14242530807/+44 203 239 8187

Browse Full Report Here–12887513

Spaglumic Acid Market 2019 Global Industry Size, Future Trends, Growth Key Factors, Demand, Business Share, Sales & Income, Manufacture Players, Application, Scope, and Opportunities Analysis by Outlook – 2024